| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |